Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20240905
Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20240903
Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20240830
Watson Biotech: Special Report on the Deposit and Actual Use of Funds Raised for the First Half of 2024
Watson Biotech: Announcement on the Company\'s Receipt of an Invention Patent Certificate
Watson Biotech: Announcement of Board Resolutions
Watson Biotech: Supervisory Board Resolution Announcement
Watson Biotech: Subsidiary Management System (August 2024)
Walvax Biotechnology: Announcement of resolutions of the 22nd meeting of the 5th board of directors.
Walvax Biotechnology: CEO Work Guidelines (August 2024)
Walvax Biotechnology: Announcement regarding the dual HPV vaccine passing WHO PQ certification.
Walvax Biotechnology: Announcement Regarding Changes in Some Senior Management Personnel of the Company.
Walvax Biotechnology: Announcement of resolution of the 21st meeting of the 5th Board of Directors.
Walvax Biotechnology: Announcement of Resolutions from the 20th Meeting of the 5th Board of Directors.
Walvax Biotechnology: Company bylaws (July 2024)
Walvax Biotechnology: Announcement of the resolution of the 19th meeting of the 5th board of directors.
Walvax Biotechnology: Announcement Regarding the Company's Receipt of Invention Patent Certificate.
Walvax Biotechnology: Notice on the receipt of two patent certificates for inventions by the company and its subsidiaries
Walvax Biotechnology: 300142 Watson Biotech Investor Relations Management Information 20240518
Walvax Biotechnology: 300142 Watson Biotech Investor Relations Management Information 20240516
No Data